JB Chemicals & Pharmaceuticals Ltd (JB Pharma), one of the fastest-growing pharmaceutical companies in India, announced a substantial price decrease of approximately 50% for the critical heart failure drug “Azmarda”. Azmarda, which contains the patented molecule Saccubutril-Valsartan® is indicated for Heart failure which ails 8 to 12 million people in the country. After the price […]
Tag: 50%
50% of Heart Attacks Now Happens in Indians Below 50 Years: Says Expert
Studies have proven that cardiovascular disease CVDs affect Indians at least a decade earlier and in their most productive midlife years compared with the people of European countries. And the rising Waist Hip Ratio (WHR) is negatively correlated with the cardiometabolic risk. The emerging risks of CVDs are caused due to the lack of a […]